CDH5 and neoplasm: At the 3-week end point, the vasculature in tumor xenografts was examined by western blot analysis (Fig 6D–6F) and immunostaining (Fig 6G–6J) to detect VEGFA and endothelial cell marker VE-Cadherin (Cdh5).